世界のトロンボポエチン市場予測 2023年-2029年

【英語タイトル】Global Thrombopoietin Market Growth 2023-2029

LP Informationが出版した調査資料(LP23DC10641)・商品コード:LP23DC10641
・発行会社(調査会社):LP Information
・発行日:2023年11月(※2025年版があります。お問い合わせください。)
・ページ数:105
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後2-3営業日)
・調査対象地域:グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
・産業分野:医薬品&医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,660 ⇒換算¥541,680見積依頼/購入/質問フォーム
Multi User(20名様閲覧用)USD5,490 ⇒換算¥812,520見積依頼/購入/質問フォーム
Corporate User(閲覧人数制限なし)USD7,320 ⇒換算¥1,083,360見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・送付(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
❖ レポートの概要 ❖

LPインフォメーションの最新刊調査レポート「世界のトロンボポエチン市場」は、過去の販売実績から2022年の世界のトロンボポエチンの総販売量を検討し、2023年から2029年の予測されるトロンボポエチンの販売量を地域別・市場分野別に包括的に分析しています。本調査レポートでは、地域別、市場分野別、サブセクター別のトロンボポエチンの市場規模を掲載し、XXX百万米ドル規模の世界のトロンボポエチン市場の詳細な分析を提供します。本インサイトレポートは、世界のトロンボポエチン業界を包括的に分析し、製品セグメント、企業情報、売上、市場シェア、最新動向、M&A活動に関する主要トレンドを明らかにしています。
また、本レポートでは、加速する世界のトロンボポエチン市場における各社の独自のポジションをより深く理解するために、トロンボポエチン製品ポートフォリオ、能力、市場参入戦略、市場でのポジション、海外展開に焦点を当て、主要なグローバル企業の戦略を分析しています。

世界のトロンボポエチン市場規模は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに成長すると予測され、2023年から2029年までの年平均成長率は000%と予測されます。トロンボポエチンの米国市場は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加し、2023年から2029年までのCAGRは000%と予測されています。トロンボポエチンの中国市場は、2023年から2029年までの年平均000%成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されます。トロンボポエチンのヨーロッパ市場は、2023年から2029年にかけて年平均000%成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されています。

トロンボポエチンの世界主要メーカーとしては、Amgen、 Novartis、 Rigel Pharmaceuticals、 R&D Systems、 Merck、 Shionogi、 MedChemExpress、 PeproTech、 Kelun、 3SBio Group、 Shanghai Fantai Biotechnology、 Beijing Biolab Technologyなどを掲載しており、売上の面では、世界の2大企業が2022年にほぼ000%のシェアを占めています。

本レポートでは、製品タイプ、用途、主要メーカー、主要地域、国別のトロンボポエチン市場の包括的な概要、市場シェア、成長機会などの情報を提供しています。

【市場細分化】

この調査ではトロンボポエチン市場をセグメンテーションし、種類別 (トロンボポエチン受容体、トロンボポエチン抗体)、用途別 (病院薬局、オンライン薬局、小売薬局、その他)、および地域別 (アジア太平洋、南北アメリカ、ヨーロッパ、および中東・アフリカ) の市場規模を予測しています。

・種類別区分:トロンボポエチン受容体、トロンボポエチン抗体

・用途別区分:病院薬局、オンライン薬局、小売薬局、その他

・地域別区分
南北アメリカ(アメリカ、カナダ、メキシコ、ブラジル)
アジア太平洋(中国、日本、韓国、東南アジア、インド、オーストラリア)
ヨーロッパ(ドイツ、フランス、イギリス、イタリア、ロシア)
中東・アフリカ(エジプト、南アフリカ、イスラエル、トルコ、GCC諸国)

【本レポートで扱う主な質問】

・世界のトロンボポエチン市場の10年間の市場状況・展望は?
・世界および地域別に見たトロンボポエチン市場成長の要因は何か?
・トロンボポエチンの市場機会はエンドマーケットの規模によってどのように変化するのか?
・トロンボポエチンのタイプ別、用途別の内訳は?
・新型コロナウイルス感染症とロシア・ウクライナ戦争の影響は?

********* 目次 *********

レポートの範囲
・市場の紹介
・分析対象期間
・調査の目的
・調査手法
・調査プロセスおよびデータソース
・経済指標
・通貨

エグゼクティブサマリー
・世界市場の概要:トロンボポエチンの年間販売量2018-2029、地域別現状・将来分析
・トロンボポエチンの種類別セグメント:トロンボポエチン受容体、トロンボポエチン抗体
・トロンボポエチンの種類別販売量:2018-2023年の販売量、売上、市場シェア、販売価格
・トロンボポエチンの用途別セグメント:病院薬局、オンライン薬局、小売薬局、その他
・トロンボポエチンの用途別販売量:2018-2023年の販売量、売上、市場シェア、販売価格

企業別世界のトロンボポエチン市場
・企業別のグローバルトロンボポエチン市場データ:2018-2023年の年間販売量、市場シェア
・企業別のトロンボポエチンの年間売上:2018-2023年の売上、市場シェア
・企業別のトロンボポエチン販売価格
・主要企業のトロンボポエチン生産地域、販売地域、製品タイプ
・市場集中度分析
・新製品および潜在的な参加者
・合併と買収、拡大

トロンボポエチンの地域別レビュー
・地域別のトロンボポエチン市場規模2018-2023:年間販売量、売上
・主要国別のトロンボポエチン市場規模2018-2023:年間販売量、売上
・南北アメリカのトロンボポエチン販売の成長
・アジア太平洋のトロンボポエチン販売の成長
・ヨーロッパのトロンボポエチン販売の成長
・中東・アフリカのトロンボポエチン販売の成長

南北アメリカ市場
・南北アメリカの国別のトロンボポエチン販売量、売上(2018-2023)
・南北アメリカのトロンボポエチンの種類別販売量
・南北アメリカのトロンボポエチンの用途別販売量
・アメリカ市場
・カナダ市場
・メキシコ市場
・ブラジル市場

アジア太平洋市場
・アジア太平洋の国別のトロンボポエチン販売量、売上(2018-2023)
・アジア太平洋のトロンボポエチンの種類別販売量
・アジア太平洋のトロンボポエチンの用途別販売量
・中国市場
・日本市場
・韓国市場
・東南アジア市場
・インド市場
・オーストラリア市場
・台湾市場

ヨーロッパ市場
・ヨーロッパの国別のトロンボポエチン販売量、売上(2018-2023)
・ヨーロッパのトロンボポエチンの種類別販売量
・ヨーロッパのトロンボポエチンの用途別販売量
・ドイツ市場
・フランス市場
・イギリス市場
・イタリア市場
・ロシア市場

中東・アフリカ市場
・中東・アフリカの国別のトロンボポエチン販売量、売上(2018-2023)
・中東・アフリカのトロンボポエチンの種類別販売量
・中東・アフリカのトロンボポエチンの用途別販売量
・エジプト市場
・南アフリカ市場
・イスラエル市場
・トルコ市場
・GCC諸国市場

市場の成長要因、課題、動向
・市場の成長要因および成長機会分析
・市場の課題およびリスク
・市場動向

製造コスト構造分析
・原材料とサプライヤー
・トロンボポエチンの製造コスト構造分析
・トロンボポエチンの製造プロセス分析
・トロンボポエチンの産業チェーン構造

マーケティング、販売業者および顧客
・販売チャンネル:直接販売チャンネル、間接販売チャンネル
・トロンボポエチンの主要なグローバル販売業者
・トロンボポエチンの主要なグローバル顧客

地域別のトロンボポエチン市場予測レビュー
・地域別のトロンボポエチン市場規模予測(2024-2029)
・南北アメリカの国別予測
・アジア太平洋の国別予測
・ヨーロッパの国別予測
・トロンボポエチンの種類別市場規模予測
・トロンボポエチンの用途別市場規模予測

主要企業分析
Amgen、 Novartis、 Rigel Pharmaceuticals、 R&D Systems、 Merck、 Shionogi、 MedChemExpress、 PeproTech、 Kelun、 3SBio Group、 Shanghai Fantai Biotechnology、 Beijing Biolab Technology
・企業情報
・トロンボポエチン製品
・トロンボポエチン販売量、売上、価格、粗利益(2018-2023)
・主要ビジネス概要
・最新動向

調査結果および結論

The global Thrombopoietin market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Thrombopoietin is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Thrombopoietin is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Thrombopoietin is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Thrombopoietin players cover Amgen, Novartis, Rigel Pharmaceuticals, R&D Systems, Merck, Shionogi, MedChemExpress, PeproTech and Kelun, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
The thrombopoietin is a physiologically significant regulator of platelet production.
LPI (LP Information)’ newest research report, the “Thrombopoietin Industry Forecast” looks at past sales and reviews total world Thrombopoietin sales in 2022, providing a comprehensive analysis by region and market sector of projected Thrombopoietin sales for 2023 through 2029. With Thrombopoietin sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Thrombopoietin industry.
This Insight Report provides a comprehensive analysis of the global Thrombopoietin landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Thrombopoietin portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Thrombopoietin market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Thrombopoietin and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Thrombopoietin.
This report presents a comprehensive overview, market shares, and growth opportunities of Thrombopoietin market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Thrombopoietin Receptor
Thrombopoietin Antibody
Segmentation by application
Hospital Pharmacy
Online Pharmacy
Retail Pharmacy
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company’s coverage, product portfolio, its market penetration.
Amgen
Novartis
Rigel Pharmaceuticals
R&D Systems
Merck
Shionogi
MedChemExpress
PeproTech
Kelun
3SBio Group
Shanghai Fantai Biotechnology
Beijing Biolab Technology
Key Questions Addressed in this Report
What is the 10-year outlook for the global Thrombopoietin market?
What factors are driving Thrombopoietin market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Thrombopoietin market opportunities vary by end market size?
How does Thrombopoietin break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

❖ レポートの目次 ❖

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Thrombopoietin Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Thrombopoietin by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Thrombopoietin by Country/Region, 2018, 2022 & 2029
2.2 Thrombopoietin Segment by Type
2.2.1 Thrombopoietin Receptor
2.2.2 Thrombopoietin Antibody
2.3 Thrombopoietin Sales by Type
2.3.1 Global Thrombopoietin Sales Market Share by Type (2018-2023)
2.3.2 Global Thrombopoietin Revenue and Market Share by Type (2018-2023)
2.3.3 Global Thrombopoietin Sale Price by Type (2018-2023)
2.4 Thrombopoietin Segment by Application
2.4.1 Hospital Pharmacy
2.4.2 Online Pharmacy
2.4.3 Retail Pharmacy
2.4.4 Others
2.5 Thrombopoietin Sales by Application
2.5.1 Global Thrombopoietin Sale Market Share by Application (2018-2023)
2.5.2 Global Thrombopoietin Revenue and Market Share by Application (2018-2023)
2.5.3 Global Thrombopoietin Sale Price by Application (2018-2023)
3 Global Thrombopoietin by Company
3.1 Global Thrombopoietin Breakdown Data by Company
3.1.1 Global Thrombopoietin Annual Sales by Company (2018-2023)
3.1.2 Global Thrombopoietin Sales Market Share by Company (2018-2023)
3.2 Global Thrombopoietin Annual Revenue by Company (2018-2023)
3.2.1 Global Thrombopoietin Revenue by Company (2018-2023)
3.2.2 Global Thrombopoietin Revenue Market Share by Company (2018-2023)
3.3 Global Thrombopoietin Sale Price by Company
3.4 Key Manufacturers Thrombopoietin Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Thrombopoietin Product Location Distribution
3.4.2 Players Thrombopoietin Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Thrombopoietin by Geographic Region
4.1 World Historic Thrombopoietin Market Size by Geographic Region (2018-2023)
4.1.1 Global Thrombopoietin Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Thrombopoietin Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Thrombopoietin Market Size by Country/Region (2018-2023)
4.2.1 Global Thrombopoietin Annual Sales by Country/Region (2018-2023)
4.2.2 Global Thrombopoietin Annual Revenue by Country/Region (2018-2023)
4.3 Americas Thrombopoietin Sales Growth
4.4 APAC Thrombopoietin Sales Growth
4.5 Europe Thrombopoietin Sales Growth
4.6 Middle East & Africa Thrombopoietin Sales Growth
5 Americas
5.1 Americas Thrombopoietin Sales by Country
5.1.1 Americas Thrombopoietin Sales by Country (2018-2023)
5.1.2 Americas Thrombopoietin Revenue by Country (2018-2023)
5.2 Americas Thrombopoietin Sales by Type
5.3 Americas Thrombopoietin Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Thrombopoietin Sales by Region
6.1.1 APAC Thrombopoietin Sales by Region (2018-2023)
6.1.2 APAC Thrombopoietin Revenue by Region (2018-2023)
6.2 APAC Thrombopoietin Sales by Type
6.3 APAC Thrombopoietin Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Thrombopoietin by Country
7.1.1 Europe Thrombopoietin Sales by Country (2018-2023)
7.1.2 Europe Thrombopoietin Revenue by Country (2018-2023)
7.2 Europe Thrombopoietin Sales by Type
7.3 Europe Thrombopoietin Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Thrombopoietin by Country
8.1.1 Middle East & Africa Thrombopoietin Sales by Country (2018-2023)
8.1.2 Middle East & Africa Thrombopoietin Revenue by Country (2018-2023)
8.2 Middle East & Africa Thrombopoietin Sales by Type
8.3 Middle East & Africa Thrombopoietin Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Thrombopoietin
10.3 Manufacturing Process Analysis of Thrombopoietin
10.4 Industry Chain Structure of Thrombopoietin
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Thrombopoietin Distributors
11.3 Thrombopoietin Customer
12 World Forecast Review for Thrombopoietin by Geographic Region
12.1 Global Thrombopoietin Market Size Forecast by Region
12.1.1 Global Thrombopoietin Forecast by Region (2024-2029)
12.1.2 Global Thrombopoietin Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Thrombopoietin Forecast by Type
12.7 Global Thrombopoietin Forecast by Application
13 Key Players Analysis
13.1 Amgen
13.1.1 Amgen Company Information
13.1.2 Amgen Thrombopoietin Product Portfolios and Specifications
13.1.3 Amgen Thrombopoietin Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Amgen Main Business Overview
13.1.5 Amgen Latest Developments
13.2 Novartis
13.2.1 Novartis Company Information
13.2.2 Novartis Thrombopoietin Product Portfolios and Specifications
13.2.3 Novartis Thrombopoietin Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Novartis Main Business Overview
13.2.5 Novartis Latest Developments
13.3 Rigel Pharmaceuticals
13.3.1 Rigel Pharmaceuticals Company Information
13.3.2 Rigel Pharmaceuticals Thrombopoietin Product Portfolios and Specifications
13.3.3 Rigel Pharmaceuticals Thrombopoietin Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Rigel Pharmaceuticals Main Business Overview
13.3.5 Rigel Pharmaceuticals Latest Developments
13.4 R&D Systems
13.4.1 R&D Systems Company Information
13.4.2 R&D Systems Thrombopoietin Product Portfolios and Specifications
13.4.3 R&D Systems Thrombopoietin Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 R&D Systems Main Business Overview
13.4.5 R&D Systems Latest Developments
13.5 Merck
13.5.1 Merck Company Information
13.5.2 Merck Thrombopoietin Product Portfolios and Specifications
13.5.3 Merck Thrombopoietin Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Merck Main Business Overview
13.5.5 Merck Latest Developments
13.6 Shionogi
13.6.1 Shionogi Company Information
13.6.2 Shionogi Thrombopoietin Product Portfolios and Specifications
13.6.3 Shionogi Thrombopoietin Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Shionogi Main Business Overview
13.6.5 Shionogi Latest Developments
13.7 MedChemExpress
13.7.1 MedChemExpress Company Information
13.7.2 MedChemExpress Thrombopoietin Product Portfolios and Specifications
13.7.3 MedChemExpress Thrombopoietin Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 MedChemExpress Main Business Overview
13.7.5 MedChemExpress Latest Developments
13.8 PeproTech
13.8.1 PeproTech Company Information
13.8.2 PeproTech Thrombopoietin Product Portfolios and Specifications
13.8.3 PeproTech Thrombopoietin Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 PeproTech Main Business Overview
13.8.5 PeproTech Latest Developments
13.9 Kelun
13.9.1 Kelun Company Information
13.9.2 Kelun Thrombopoietin Product Portfolios and Specifications
13.9.3 Kelun Thrombopoietin Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Kelun Main Business Overview
13.9.5 Kelun Latest Developments
13.10 3SBio Group
13.10.1 3SBio Group Company Information
13.10.2 3SBio Group Thrombopoietin Product Portfolios and Specifications
13.10.3 3SBio Group Thrombopoietin Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 3SBio Group Main Business Overview
13.10.5 3SBio Group Latest Developments
13.11 Shanghai Fantai Biotechnology
13.11.1 Shanghai Fantai Biotechnology Company Information
13.11.2 Shanghai Fantai Biotechnology Thrombopoietin Product Portfolios and Specifications
13.11.3 Shanghai Fantai Biotechnology Thrombopoietin Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Shanghai Fantai Biotechnology Main Business Overview
13.11.5 Shanghai Fantai Biotechnology Latest Developments
13.12 Beijing Biolab Technology
13.12.1 Beijing Biolab Technology Company Information
13.12.2 Beijing Biolab Technology Thrombopoietin Product Portfolios and Specifications
13.12.3 Beijing Biolab Technology Thrombopoietin Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Beijing Biolab Technology Main Business Overview
13.12.5 Beijing Biolab Technology Latest Developments
14 Research Findings and Conclusion

List of Tables
Table 1. Thrombopoietin Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Thrombopoietin Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Thrombopoietin Receptor
Table 4. Major Players of Thrombopoietin Antibody
Table 5. Global Thrombopoietin Sales by Type (2018-2023) & (K Units)
Table 6. Global Thrombopoietin Sales Market Share by Type (2018-2023)
Table 7. Global Thrombopoietin Revenue by Type (2018-2023) & ($ million)
Table 8. Global Thrombopoietin Revenue Market Share by Type (2018-2023)
Table 9. Global Thrombopoietin Sale Price by Type (2018-2023) & (US$/Unit)
Table 10. Global Thrombopoietin Sales by Application (2018-2023) & (K Units)
Table 11. Global Thrombopoietin Sales Market Share by Application (2018-2023)
Table 12. Global Thrombopoietin Revenue by Application (2018-2023)
Table 13. Global Thrombopoietin Revenue Market Share by Application (2018-2023)
Table 14. Global Thrombopoietin Sale Price by Application (2018-2023) & (US$/Unit)
Table 15. Global Thrombopoietin Sales by Company (2018-2023) & (K Units)
Table 16. Global Thrombopoietin Sales Market Share by Company (2018-2023)
Table 17. Global Thrombopoietin Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Thrombopoietin Revenue Market Share by Company (2018-2023)
Table 19. Global Thrombopoietin Sale Price by Company (2018-2023) & (US$/Unit)
Table 20. Key Manufacturers Thrombopoietin Producing Area Distribution and Sales Area
Table 21. Players Thrombopoietin Products Offered
Table 22. Thrombopoietin Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Thrombopoietin Sales by Geographic Region (2018-2023) & (K Units)
Table 26. Global Thrombopoietin Sales Market Share Geographic Region (2018-2023)
Table 27. Global Thrombopoietin Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Thrombopoietin Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Thrombopoietin Sales by Country/Region (2018-2023) & (K Units)
Table 30. Global Thrombopoietin Sales Market Share by Country/Region (2018-2023)
Table 31. Global Thrombopoietin Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Thrombopoietin Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Thrombopoietin Sales by Country (2018-2023) & (K Units)
Table 34. Americas Thrombopoietin Sales Market Share by Country (2018-2023)
Table 35. Americas Thrombopoietin Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Thrombopoietin Revenue Market Share by Country (2018-2023)
Table 37. Americas Thrombopoietin Sales by Type (2018-2023) & (K Units)
Table 38. Americas Thrombopoietin Sales by Application (2018-2023) & (K Units)
Table 39. APAC Thrombopoietin Sales by Region (2018-2023) & (K Units)
Table 40. APAC Thrombopoietin Sales Market Share by Region (2018-2023)
Table 41. APAC Thrombopoietin Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Thrombopoietin Revenue Market Share by Region (2018-2023)
Table 43. APAC Thrombopoietin Sales by Type (2018-2023) & (K Units)
Table 44. APAC Thrombopoietin Sales by Application (2018-2023) & (K Units)
Table 45. Europe Thrombopoietin Sales by Country (2018-2023) & (K Units)
Table 46. Europe Thrombopoietin Sales Market Share by Country (2018-2023)
Table 47. Europe Thrombopoietin Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Thrombopoietin Revenue Market Share by Country (2018-2023)
Table 49. Europe Thrombopoietin Sales by Type (2018-2023) & (K Units)
Table 50. Europe Thrombopoietin Sales by Application (2018-2023) & (K Units)
Table 51. Middle East & Africa Thrombopoietin Sales by Country (2018-2023) & (K Units)
Table 52. Middle East & Africa Thrombopoietin Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Thrombopoietin Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Thrombopoietin Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Thrombopoietin Sales by Type (2018-2023) & (K Units)
Table 56. Middle East & Africa Thrombopoietin Sales by Application (2018-2023) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Thrombopoietin
Table 58. Key Market Challenges & Risks of Thrombopoietin
Table 59. Key Industry Trends of Thrombopoietin
Table 60. Thrombopoietin Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Thrombopoietin Distributors List
Table 63. Thrombopoietin Customer List
Table 64. Global Thrombopoietin Sales Forecast by Region (2024-2029) & (K Units)
Table 65. Global Thrombopoietin Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Thrombopoietin Sales Forecast by Country (2024-2029) & (K Units)
Table 67. Americas Thrombopoietin Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Thrombopoietin Sales Forecast by Region (2024-2029) & (K Units)
Table 69. APAC Thrombopoietin Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Thrombopoietin Sales Forecast by Country (2024-2029) & (K Units)
Table 71. Europe Thrombopoietin Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Thrombopoietin Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Middle East & Africa Thrombopoietin Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Thrombopoietin Sales Forecast by Type (2024-2029) & (K Units)
Table 75. Global Thrombopoietin Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Thrombopoietin Sales Forecast by Application (2024-2029) & (K Units)
Table 77. Global Thrombopoietin Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Amgen Basic Information, Thrombopoietin Manufacturing Base, Sales Area and Its Competitors
Table 79. Amgen Thrombopoietin Product Portfolios and Specifications
Table 80. Amgen Thrombopoietin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 81. Amgen Main Business
Table 82. Amgen Latest Developments
Table 83. Novartis Basic Information, Thrombopoietin Manufacturing Base, Sales Area and Its Competitors
Table 84. Novartis Thrombopoietin Product Portfolios and Specifications
Table 85. Novartis Thrombopoietin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 86. Novartis Main Business
Table 87. Novartis Latest Developments
Table 88. Rigel Pharmaceuticals Basic Information, Thrombopoietin Manufacturing Base, Sales Area and Its Competitors
Table 89. Rigel Pharmaceuticals Thrombopoietin Product Portfolios and Specifications
Table 90. Rigel Pharmaceuticals Thrombopoietin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 91. Rigel Pharmaceuticals Main Business
Table 92. Rigel Pharmaceuticals Latest Developments
Table 93. R&D Systems Basic Information, Thrombopoietin Manufacturing Base, Sales Area and Its Competitors
Table 94. R&D Systems Thrombopoietin Product Portfolios and Specifications
Table 95. R&D Systems Thrombopoietin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 96. R&D Systems Main Business
Table 97. R&D Systems Latest Developments
Table 98. Merck Basic Information, Thrombopoietin Manufacturing Base, Sales Area and Its Competitors
Table 99. Merck Thrombopoietin Product Portfolios and Specifications
Table 100. Merck Thrombopoietin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 101. Merck Main Business
Table 102. Merck Latest Developments
Table 103. Shionogi Basic Information, Thrombopoietin Manufacturing Base, Sales Area and Its Competitors
Table 104. Shionogi Thrombopoietin Product Portfolios and Specifications
Table 105. Shionogi Thrombopoietin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 106. Shionogi Main Business
Table 107. Shionogi Latest Developments
Table 108. MedChemExpress Basic Information, Thrombopoietin Manufacturing Base, Sales Area and Its Competitors
Table 109. MedChemExpress Thrombopoietin Product Portfolios and Specifications
Table 110. MedChemExpress Thrombopoietin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 111. MedChemExpress Main Business
Table 112. MedChemExpress Latest Developments
Table 113. PeproTech Basic Information, Thrombopoietin Manufacturing Base, Sales Area and Its Competitors
Table 114. PeproTech Thrombopoietin Product Portfolios and Specifications
Table 115. PeproTech Thrombopoietin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 116. PeproTech Main Business
Table 117. PeproTech Latest Developments
Table 118. Kelun Basic Information, Thrombopoietin Manufacturing Base, Sales Area and Its Competitors
Table 119. Kelun Thrombopoietin Product Portfolios and Specifications
Table 120. Kelun Thrombopoietin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 121. Kelun Main Business
Table 122. Kelun Latest Developments
Table 123. 3SBio Group Basic Information, Thrombopoietin Manufacturing Base, Sales Area and Its Competitors
Table 124. 3SBio Group Thrombopoietin Product Portfolios and Specifications
Table 125. 3SBio Group Thrombopoietin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 126. 3SBio Group Main Business
Table 127. 3SBio Group Latest Developments
Table 128. Shanghai Fantai Biotechnology Basic Information, Thrombopoietin Manufacturing Base, Sales Area and Its Competitors
Table 129. Shanghai Fantai Biotechnology Thrombopoietin Product Portfolios and Specifications
Table 130. Shanghai Fantai Biotechnology Thrombopoietin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 131. Shanghai Fantai Biotechnology Main Business
Table 132. Shanghai Fantai Biotechnology Latest Developments
Table 133. Beijing Biolab Technology Basic Information, Thrombopoietin Manufacturing Base, Sales Area and Its Competitors
Table 134. Beijing Biolab Technology Thrombopoietin Product Portfolios and Specifications
Table 135. Beijing Biolab Technology Thrombopoietin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 136. Beijing Biolab Technology Main Business
Table 137. Beijing Biolab Technology Latest Developments
List of Figures
Figure 1. Picture of Thrombopoietin
Figure 2. Thrombopoietin Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Thrombopoietin Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Thrombopoietin Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Thrombopoietin Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Thrombopoietin Receptor
Figure 10. Product Picture of Thrombopoietin Antibody
Figure 11. Global Thrombopoietin Sales Market Share by Type in 2022
Figure 12. Global Thrombopoietin Revenue Market Share by Type (2018-2023)
Figure 13. Thrombopoietin Consumed in Hospital Pharmacy
Figure 14. Global Thrombopoietin Market: Hospital Pharmacy (2018-2023) & (K Units)
Figure 15. Thrombopoietin Consumed in Online Pharmacy
Figure 16. Global Thrombopoietin Market: Online Pharmacy (2018-2023) & (K Units)
Figure 17. Thrombopoietin Consumed in Retail Pharmacy
Figure 18. Global Thrombopoietin Market: Retail Pharmacy (2018-2023) & (K Units)
Figure 19. Thrombopoietin Consumed in Others
Figure 20. Global Thrombopoietin Market: Others (2018-2023) & (K Units)
Figure 21. Global Thrombopoietin Sales Market Share by Application (2022)
Figure 22. Global Thrombopoietin Revenue Market Share by Application in 2022
Figure 23. Thrombopoietin Sales Market by Company in 2022 (K Units)
Figure 24. Global Thrombopoietin Sales Market Share by Company in 2022
Figure 25. Thrombopoietin Revenue Market by Company in 2022 ($ Million)
Figure 26. Global Thrombopoietin Revenue Market Share by Company in 2022
Figure 27. Global Thrombopoietin Sales Market Share by Geographic Region (2018-2023)
Figure 28. Global Thrombopoietin Revenue Market Share by Geographic Region in 2022
Figure 29. Americas Thrombopoietin Sales 2018-2023 (K Units)
Figure 30. Americas Thrombopoietin Revenue 2018-2023 ($ Millions)
Figure 31. APAC Thrombopoietin Sales 2018-2023 (K Units)
Figure 32. APAC Thrombopoietin Revenue 2018-2023 ($ Millions)
Figure 33. Europe Thrombopoietin Sales 2018-2023 (K Units)
Figure 34. Europe Thrombopoietin Revenue 2018-2023 ($ Millions)
Figure 35. Middle East & Africa Thrombopoietin Sales 2018-2023 (K Units)
Figure 36. Middle East & Africa Thrombopoietin Revenue 2018-2023 ($ Millions)
Figure 37. Americas Thrombopoietin Sales Market Share by Country in 2022
Figure 38. Americas Thrombopoietin Revenue Market Share by Country in 2022
Figure 39. Americas Thrombopoietin Sales Market Share by Type (2018-2023)
Figure 40. Americas Thrombopoietin Sales Market Share by Application (2018-2023)
Figure 41. United States Thrombopoietin Revenue Growth 2018-2023 ($ Millions)
Figure 42. Canada Thrombopoietin Revenue Growth 2018-2023 ($ Millions)
Figure 43. Mexico Thrombopoietin Revenue Growth 2018-2023 ($ Millions)
Figure 44. Brazil Thrombopoietin Revenue Growth 2018-2023 ($ Millions)
Figure 45. APAC Thrombopoietin Sales Market Share by Region in 2022
Figure 46. APAC Thrombopoietin Revenue Market Share by Regions in 2022
Figure 47. APAC Thrombopoietin Sales Market Share by Type (2018-2023)
Figure 48. APAC Thrombopoietin Sales Market Share by Application (2018-2023)
Figure 49. China Thrombopoietin Revenue Growth 2018-2023 ($ Millions)
Figure 50. Japan Thrombopoietin Revenue Growth 2018-2023 ($ Millions)
Figure 51. South Korea Thrombopoietin Revenue Growth 2018-2023 ($ Millions)
Figure 52. Southeast Asia Thrombopoietin Revenue Growth 2018-2023 ($ Millions)
Figure 53. India Thrombopoietin Revenue Growth 2018-2023 ($ Millions)
Figure 54. Australia Thrombopoietin Revenue Growth 2018-2023 ($ Millions)
Figure 55. China Taiwan Thrombopoietin Revenue Growth 2018-2023 ($ Millions)
Figure 56. Europe Thrombopoietin Sales Market Share by Country in 2022
Figure 57. Europe Thrombopoietin Revenue Market Share by Country in 2022
Figure 58. Europe Thrombopoietin Sales Market Share by Type (2018-2023)
Figure 59. Europe Thrombopoietin Sales Market Share by Application (2018-2023)
Figure 60. Germany Thrombopoietin Revenue Growth 2018-2023 ($ Millions)
Figure 61. France Thrombopoietin Revenue Growth 2018-2023 ($ Millions)
Figure 62. UK Thrombopoietin Revenue Growth 2018-2023 ($ Millions)
Figure 63. Italy Thrombopoietin Revenue Growth 2018-2023 ($ Millions)
Figure 64. Russia Thrombopoietin Revenue Growth 2018-2023 ($ Millions)
Figure 65. Middle East & Africa Thrombopoietin Sales Market Share by Country in 2022
Figure 66. Middle East & Africa Thrombopoietin Revenue Market Share by Country in 2022
Figure 67. Middle East & Africa Thrombopoietin Sales Market Share by Type (2018-2023)
Figure 68. Middle East & Africa Thrombopoietin Sales Market Share by Application (2018-2023)
Figure 69. Egypt Thrombopoietin Revenue Growth 2018-2023 ($ Millions)
Figure 70. South Africa Thrombopoietin Revenue Growth 2018-2023 ($ Millions)
Figure 71. Israel Thrombopoietin Revenue Growth 2018-2023 ($ Millions)
Figure 72. Turkey Thrombopoietin Revenue Growth 2018-2023 ($ Millions)
Figure 73. GCC Country Thrombopoietin Revenue Growth 2018-2023 ($ Millions)
Figure 74. Manufacturing Cost Structure Analysis of Thrombopoietin in 2022
Figure 75. Manufacturing Process Analysis of Thrombopoietin
Figure 76. Industry Chain Structure of Thrombopoietin
Figure 77. Channels of Distribution
Figure 78. Global Thrombopoietin Sales Market Forecast by Region (2024-2029)
Figure 79. Global Thrombopoietin Revenue Market Share Forecast by Region (2024-2029)
Figure 80. Global Thrombopoietin Sales Market Share Forecast by Type (2024-2029)
Figure 81. Global Thrombopoietin Revenue Market Share Forecast by Type (2024-2029)
Figure 82. Global Thrombopoietin Sales Market Share Forecast by Application (2024-2029)
Figure 83. Global Thrombopoietin Revenue Market Share Forecast by Application (2024-2029)


★調査レポート[世界のトロンボポエチン市場予測 2023年-2029年] (コード:LP23DC10641)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のトロンボポエチン市場予測 2023年-2029年]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆